photocreo-michal-bednarek-shutterstock-com

PHOTOCREO Michal Bednarek / Shutterstock.com

13 August 2015Peter Pitts

Why biopharma patents should be free from PTAB clutches

The UK’s pharmaceutical industry reportedly employs more than 70,000 workers and in 2013 contributed around £13 billion ($20.2 billion) to the economy.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Diverging in the detail: UPC local divisions and Court of Appeal take different paths

Three reasons why the UK should reconsider joining the UPC

Ukraine law change means rightsholders need to prepare

Commercialising genomic tech in Nigeria

Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO

In vivo cell therapy: A world beyond ex vivo engineering

Interpreting the SPC manufacturing waiver: EU courts diverge

Abbott v Sibio: A game-changer for UPC tech disputes